SARAH HUNT: Open Payments
NPI 1336122571 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$270 in 14 payments from 7 companies in 2025. Trend: 2023 $447 · 2024 $262 · 2025 $270
Food & beverage: $270
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $109 |
| Novartis Pharmaceuticals Corporation | 3 | $43 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| Edwards Lifesciences Corporation | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| PFIZER INC. | 1 | $17 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $12 |
Products named: Ozempic, ELIQUIS, ENTRESTO, SAPIEN 3 Ultra RESILIA, Kerendia, Wegovy, LEQVIO, LifeVest.
Industry payments across IN — which companies pay providers there.
